Problem / Solution / Doublelock advantage
The Problem
The DoubleLock Advantage
The Solution
Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in
Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in the facility’s care; 10% of these patients die each year from such HAIs. In 2007 the Centers for Disease Control stated that catheter-related bloodstream, surgical site, and antibiotic-resistant HAIs cost the U.S. Healthcare system $13 billion and cause 99,000 preventable deaths annually.
The Solution
The DoubleLock Advantage
The Solution
DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syring
DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syringe tip asepsis.
Prototype #11 is shown in the images.
Contact Us to View
Laboratory Results
The DoubleLock Advantage
The DoubleLock Advantage
The DoubleLock Advantage
Antibacterial cover - No Bacteria; Increased Safety - No Needles; Reduced Legal and Care Costs; Time Savings; Ease of Use; Decreased Toxic Drug Vapors and Leakage; Ensures Compliance with IV Port Asepsis - No Alcohol Swabs or Alcohol Impregnated Caps Needed.
View Demonstration Video
The Problem
The Problem
Intravenous ports and syringe tips are exposed, easily contaminated, and implicated in contributing to a healthcare-associated infection (HAI) according to published research. Per a 2022 study by the World Health Organization and pending the country where care is provided, 7-15% of patients in acute care hospitals acquire an HAI while in the facility’s care; 10% of these patients die each year from such HAIs. The Centers for Disease Control states that catheter-related bloodstream, surgical site, and antibiotic-resistant HAIs cost the U.S. Healthcare system $13 billion and cause 99,000 preventable deaths annually.
The DoubleLock Advantage
Increased Safety - No Needles; Reduced Legal and Care Costs; Time Savings; Ease of Use; Decreased Toxic Drug Vapors and Leakage; Ensures Compliance with IV Port Asepsis - No Alcohol Swabs or Alcohol Impregnated Caps Needed